Researchers are exploring treatments that will keep people with cystic fibrosis as healthy as possible until a cure is found. In the first plenary at the NACFC, two CF scientists explain the progress of current research.
Site Search
Showing 1 - 10 of 107 results
News
|
May 6, 2011
|
1 min read
News
|
Nov. 8, 2011
|
2 min read
Katherine Tuggle, Ph.D.
|
7 min read
For those of us without a medication that targets our cystic fibrosis mutation, it's important to remember that our life with CF is a marathon.
Jerry Cahill
|
4 min read
In the third plenary, Dr. Wayne Morgan talked about the connection between cystic fibrosis care and the Patient Registry, and introduced a new way for people with CF, along with their families, to help shape the research conducted using the Registry.
Aliza Fink, D.Sc.
|
4 min read
A day spent visiting a care center proved the perfect introduction to the CF story for legislative staffers.
Stacey Falardeau
|
4 min read
The New England Journal of Medicine, the world's most influential and widely read medical periodical, features a study this week about a Phase 2 clinical trial of VX-770, an oral drug in development that targets the root cause of cystic fibrosis.
News
|
Nov. 17, 2010
|
3 min read
News
|
Sept. 16, 2008
|
1 min read
News
|
April 11, 2008
|
1 min read
News
|
Aug. 20, 2008
|
1 min read